The bulk of the publications resulting from the SCANDAT collaboration can be found in transfusion journals, but we have also published papers in general internal medicine and oncology journals. For a complete listing, see below:

1.
Edgren G, Hjalgrim H, Rostgaard K, et al. Searching for unknown transfusion-transmitted hepatitis viruses: a binational cohort study of 1.5 million transfused patients. J Intern Med. 2018;284(1):92-103. [PubMed]
2.
Just S, Rostgaard K, Titlestad K, et al. Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study. Ann Rheum Dis. March 2018. [PubMed]
3.
Zhao J, Rydén J, Wikman A, et al. Blood use in hematologic malignancies: a nationwide overview in Sweden between 2000 and 2010. Transfusion. 2018;58(2):390-401. [PubMed]
4.
Kreuger A, Rostgaard K, Middelburg R, et al. Storage time of platelet concentrates and risk of a positive blood culture: a nationwide cohort study. Transfusion. 2018;58(1):16-24. [PubMed]
5.
Edgren G, Hjalgrim H. Epidemiology of donors and recipients: lessons from the SCANDAT database. Transfus Med. November 2017. [PubMed]
6.
Ludvigsson J, Lebwohl B, Green P, Murray J, Hjalgrim H, Edgren G. Is Blood Transfusion Linked to Celiac Disease? A Nationwide Cohort Study. Am J Epidemiol. 2018;187(1):120-124. [PubMed]
7.
Edgren G, Ullum H, Rostgaard K, et al. Association of Donor Age and Sex With Survival of Patients Receiving Transfusions. JAMA Intern Med. 2017;177(6):854-860. [PubMed]
8.
Burgdorf K, Simonsen J, Sundby A, et al. Socio-demographic characteristics of Danish blood donors. PLoS One. 2017;12(2):e0169112. [PubMed]
9.
Ludvigsson J, Sjölander A, Murray J, Hjalgrim H, Edgren G. Haemoglobin decline before coeliac disease diagnosis: a nationwide transfusion cohort study of 1.1 million blood donors. Gut. 2017;66(11):2036-2037. [PubMed]
10.
Halmin M, Rostgaard K, Lee B, et al. Length of Storage of Red Blood Cells and Patient Survival After Blood Transfusion: A Binational Cohort Study. Ann Intern Med. 2017;166(4):248-256. [PubMed]
11.
Kotzé S, Pedersen O, Petersen M, et al. Deferral for low hemoglobin is not associated with increased risk of infection in Danish blood donors. Transfusion. 2017;57(3):571-577. [PubMed]
12.
Holzmann M, Sartipy U, Olsson M, Dickman P, Edgren G. Sex-Discordant Blood Transfusions and Survival After Cardiac Surgery: A Nationwide Cohort Study. Circulation. 2016;134(21):1692-1694. [PubMed]
13.
Grau K, Vasan S, Rostgaard K, et al. No association between frequent apheresis donation and risk of fractures: a retrospective cohort analysis from Sweden. Transfusion. 2017;57(2):390-396. [PubMed]
14.
Vasan S, Hwang J, Rostgaard K, et al. ABO blood group and risk of cancer: A register-based cohort study of 1.6 million blood donors. Cancer Epidemiol. 2016;44:40-43. [PubMed]
15.
Edgren G, Hjalgrim H, Rostgaard K, et al. Transmission of Neurodegenerative Disorders Through Blood Transfusion: A Cohort Study. Ann Intern Med. 2016;165(5):316-324. [PubMed]
16.
Vasan S, Rostgaard K, Majeed A, et al. ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors. Circulation. 2016;133(15):1449-57; discussion 1457. [PubMed]
17.
Halmin M, Chiesa F, Vasan S, et al. Epidemiology of Massive Transfusion: A Binational Study From Sweden and Denmark. Crit Care Med. 2016;44(3):468-477. [PubMed]
18.
Edgren G, Nyrén O, Hultcrantz M, et al. Blood donation and risk of polycythemia vera. Transfusion. 2016;56(6 Pt 2):1622-1627. [PubMed]
19.
Vasan S, Chiesa F, Rostgaard K, et al. Lack of association between blood donor age and survival of transfused patients. Blood. 2016;127(5):658-661. [PubMed]
20.
Sartipy U, Holzmann M, Hjalgrim H, Edgren G. Red Blood Cell Concentrate Storage and Survival After Cardiac Surgery. JAMA. 2015;314(15):1641-1643. [PubMed]
21.
Hjalgrim H, Rostgaard K, Vasan S, et al. No evidence of transmission of chronic lymphocytic leukemia through blood transfusion. Blood. 2015;126(17):2059-2061. [PubMed]
22.
Ullum H, Rostgaard K, Kamper-Jørgensen M, et al. Blood donation and blood donor mortality after adjustment for a healthy donor effect. Transfusion. 2015;55(10):2479-2485. [PubMed]
23.
Vasan S, Rostgaard K, Ullum H, Melbye M, Hjalgrim H, Edgren G. ABO Blood Group and Dementia Risk–A Scandinavian Record-Linkage Study. PLoS One. 2015;10(6):e0129115. [PubMed]
24.
Pedersen O, Axel S, Rostgaard K, et al. The heritability of blood donation: a population-based nationwide twin study. Transfusion. 2015;55(9):2169-74; quiz 2168. [PubMed]
25.
Edgren G, Rostgaard K, Vasan S, et al. The new Scandinavian Donations and Transfusions database (SCANDAT2): a blood safety resource with added versatility. Transfusion. 2015;55(7):1600-1606. [PubMed]
26.
Norda R, Andersson T, Edgren G, Nyren O, Reilly M. The impact of plasma preparations and their storage time on short-term posttransfusion mortality: a population-based study using the Scandinavian Donation and Transfusion database. J Trauma Acute Care Surg. 2012;72(4):954-960. [PubMed]
27.
Edgren G, Hjalgrim H, Rostgaard K, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol. 2010;172(11):1280-1285. [PubMed]
28.
Edgren G, Hjalgrim H. Epidemiological considerations for the use of databases in transfusion research: a Scandinavian perspective. Curr Opin Hematol. 2010;17(6):596-601. [PubMed]
29.
Edgren G, Kamper-Jørgensen M, Eloranta S, et al. Duration of red blood cell storage and survival of transfused patients (CME). Transfusion. 2010;50(6):1185-1195. [PubMed]
30.
Tynell E, Andersson T, Norda R, et al. Should plasma from female donors be avoided? A population-based cohort study of plasma recipients in Sweden from 1990 through 2002. Transfusion. 2010;50(6):1249-1256. [PubMed]
31.
Kamper-Jørgensen M, Hjalgrim H, Edgren G, et al. Expensive blood safety initiatives may offer less benefit than we think. Transfusion. 2010;50(1):240-242. [PubMed]
32.
Shanwell A, Andersson T, Rostgaard K, et al. Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma. Vox Sang. 2009;96(4):316-323. [PubMed]
33.
Kamper-Jørgensen M, Edgren G, Rostgaard K, et al. Blood transfusion exposure in Denmark and Sweden. Transfusion. 2009;49(5):888-894. [PubMed]
34.
Kamper-Jørgensen M, Ahlgren M, Rostgaard K, et al. Survival after blood transfusion. Transfusion. 2008;48(12):2577-2584. [PubMed]
35.
Edgren G, Reilly M, Hjalgrim H, et al. Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst. 2008;100(8):572-579. [PubMed]
36.
Edgren G, Tran T, Hjalgrim H, et al. Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion. 2007;47(11):2017-2024. [PubMed]
37.
Edgren G, Hjalgrim H, Reilly M, et al. Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet. 2007;369(9574):1724-1730. [PubMed]
38.
Edgren G, Hjalgrim H, Tran T, et al. A population-based binational register for monitoring long-term outcome and possible disease concordance among blood donors and recipients. Vox Sang. 2006;91(4):316-323. [PubMed]
39.
Edgren G, Bagnardi V, Bellocco R, et al. Pattern of declining hemoglobin concentration before cancer diagnosis. Int J Cancer. 2010;127(6):1429-1436. [PubMed]
40.
Hjalgrim H, Edgren G, Rostgaard K, et al. Cancer incidence in blood transfusion recipients. J Natl Cancer Inst. 2007;99(24):1864-1874. [PubMed]